ClinConnect ClinConnect Logo
Search / Trial NCT04860570

Are Double-ring Wound-edge Protectors Effective for Preventing Superficial Surgical Site Infection After Open Appendectomy?

Launched by HOSPITAL MEDINA DEL CAMPO · Apr 22, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Acute Appendicitis Double Ring Wound Edge Protector Superficial Surgical Site Infection

ClinConnect Summary

This clinical trial is studying whether using special double-ring wound-edge protectors can help prevent infections at the surgery site after an open appendectomy, which is a common operation to remove the appendix due to acute appendicitis. The trial is currently looking for participants who are at least 15 years old and have been diagnosed with acute appendicitis. It includes patients who are treated with either the open appendectomy method with the wound-edge protector or laparoscopic appendectomy, regardless of their risk factors for infections, like obesity or diabetes.

Participants in this study can expect to receive standard care for their appendicitis, and their recovery will be monitored for at least 30 days after surgery to see if the wound-edge protectors make a difference in preventing infections. It’s important to note that patients who received antibiotics before surgery and those with issues unrelated to the appendix will not be included in the trial. This study aims to provide valuable information that could improve care for future patients undergoing this type of surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age of at least 15 years old.
  • Clinical diagnosis of acute appendicitis.
  • Treated by: Open appendectomy + double-ring wound-edge protector or Laparoscopic appendectomy.
  • Note: with the aim of avoiding selection bias, all patients presenting risk factors for surgical site infections (eg obesity, diabetes, malnourishment, immunosupression, etc.) will be included in the present study.
  • Exclusion Criteria:
  • Patients who did not receive prophylactic antibiotic.
  • Source of abdominal pathology other than the caecal appendix.
  • Follow-up period less than 30 days.

About Hospital Medina Del Campo

Hospital Medina del Campo is a prominent healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and scientific integrity, the hospital collaborates with multidisciplinary teams to explore new therapies and treatment modalities. Its state-of-the-art facilities and experienced staff foster an environment conducive to rigorous clinical investigation, ensuring that research initiatives align with the highest ethical standards and regulatory requirements. Hospital Medina del Campo is poised to contribute significantly to the evolving landscape of medical science, enhancing the quality of healthcare for the community and beyond.

Locations

Medina Del Campo, , Spain

Patients applied

0 patients applied

Trial Officials

Johnn Henry Herrera Kok

Principal Investigator

Complejo Asistencial Universitario de León, Spain

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials